
Michael Lee
Examiner (ID: 12147, Phone: (571)272-7349 , Office: P/2422 )
| Most Active Art Unit | 2422 |
| Art Unit(s) | 2622, 2422, 2714, 2614, 2711, 1661, 2602 |
| Total Applications | 3017 |
| Issued Applications | 2434 |
| Pending Applications | 176 |
| Abandoned Applications | 432 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14893747
[patent_doc_number] => 20190290639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/438956
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438956 | COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS | Jun 11, 2019 | Abandoned |
Array
(
[id] => 19624059
[patent_doc_number] => 12162863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Modulators of stimulator of interferon genes (STING)
[patent_app_type] => utility
[patent_app_number] => 17/251291
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53596
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251291 | Modulators of stimulator of interferon genes (STING) | Jun 11, 2019 | Issued |
Array
(
[id] => 15052271
[patent_doc_number] => 10456411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
[patent_app_type] => utility
[patent_app_number] => 16/437773
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6881
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16437773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/437773 | Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor | Jun 10, 2019 | Issued |
Array
(
[id] => 14926121
[patent_doc_number] => 20190298698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/433097
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433097 | Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function | Jun 5, 2019 | Issued |
Array
(
[id] => 19256802
[patent_doc_number] => 12016831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Polidocanol for use as immunomodulating agent
[patent_app_type] => utility
[patent_app_number] => 15/734825
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5752
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734825 | Polidocanol for use as immunomodulating agent | Jun 4, 2019 | Issued |
Array
(
[id] => 16960822
[patent_doc_number] => 20210212321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => STABILIZED FUNGICIDAL COMPOSITION COMPRISING CYCLODEXTRIN
[patent_app_type] => utility
[patent_app_number] => 15/734111
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734111 | STABILIZED FUNGICIDAL COMPOSITION COMPRISING CYCLODEXTRIN | May 29, 2019 | Abandoned |
Array
(
[id] => 16945849
[patent_doc_number] => 20210204540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => METHOD OF CONTROLLING POWDERY MILDEW
[patent_app_type] => utility
[patent_app_number] => 17/059797
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059797 | METHOD OF CONTROLLING POWDERY MILDEW | May 28, 2019 | Abandoned |
Array
(
[id] => 14833147
[patent_doc_number] => 20190274974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Treatment of Pain Associated with Trigeminal Neuralgia
[patent_app_type] => utility
[patent_app_number] => 16/423423
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423423 | Treatment of Pain Associated with Trigeminal Neuralgia | May 27, 2019 | Pending |
Array
(
[id] => 19651250
[patent_doc_number] => 12173018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Penicillin-binding protein inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/057593
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49950
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057593 | Penicillin-binding protein inhibitors | May 22, 2019 | Issued |
Array
(
[id] => 15738327
[patent_doc_number] => 20200108051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => METHODS OF TREATING HEPATIC ENCEPHALOPATHY
[patent_app_type] => utility
[patent_app_number] => 16/414018
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414018 | Methods of treating hepatic encephalopathy | May 15, 2019 | Issued |
Array
(
[id] => 16435592
[patent_doc_number] => 20200352917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => MEDICATED SPRAY FOR TREATMENT OF SUBSTANCE ABUSE, OVERDOSE, ADDICTION AND IMPULSE CONTROL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/404462
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404462 | MEDICATED SPRAY FOR TREATMENT OF SUBSTANCE ABUSE, OVERDOSE, ADDICTION AND IMPULSE CONTROL DISORDERS | May 5, 2019 | Abandoned |
Array
(
[id] => 15279979
[patent_doc_number] => 10512639
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-12-24
[patent_title] => Therapeutic agents for treating diseases associated with chronic inflammation and screening method
[patent_app_type] => utility
[patent_app_number] => 16/396719
[patent_app_country] => US
[patent_app_date] => 2019-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 4053
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396719
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396719 | Therapeutic agents for treating diseases associated with chronic inflammation and screening method | Apr 27, 2019 | Issued |
Array
(
[id] => 16589260
[patent_doc_number] => 10898502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Treatment of diseases using a combination of ultraviolet blood irradiation and antibiotics
[patent_app_type] => utility
[patent_app_number] => 16/378685
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7050
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16378685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/378685 | Treatment of diseases using a combination of ultraviolet blood irradiation and antibiotics | Apr 8, 2019 | Issued |
Array
(
[id] => 19089667
[patent_doc_number] => 11951086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Tablet or composition having n-acyl ethanolamine and cannabinoid
[patent_app_type] => utility
[patent_app_number] => 17/044521
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 3670
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044521 | Tablet or composition having n-acyl ethanolamine and cannabinoid | Apr 2, 2019 | Issued |
Array
(
[id] => 16569076
[patent_doc_number] => 20210008082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP
[patent_app_type] => utility
[patent_app_number] => 17/041214
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041214 | Fragrance compositions and use thereof for improving sleep | Mar 31, 2019 | Issued |
Array
(
[id] => 15102175
[patent_doc_number] => 10472387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Inhibitors of glucocorticoid receptor
[patent_app_type] => utility
[patent_app_number] => 16/365422
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39687
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365422
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365422 | Inhibitors of glucocorticoid receptor | Mar 25, 2019 | Issued |
Array
(
[id] => 16954841
[patent_doc_number] => 11058668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Methods of treating TTR amyloidosis using AG10
[patent_app_type] => utility
[patent_app_number] => 16/361587
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 72
[patent_no_of_words] => 30205
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361587 | Methods of treating TTR amyloidosis using AG10 | Mar 21, 2019 | Issued |
Array
(
[id] => 14893713
[patent_doc_number] => 20190290622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => Compositions and Methods for Treating Opioid Overdose and Opioid Abuse
[patent_app_type] => utility
[patent_app_number] => 16/361426
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361426
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361426 | Compositions and methods for treating opioid overdose and opioid abuse | Mar 21, 2019 | Issued |
Array
(
[id] => 14893699
[patent_doc_number] => 20190290615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => NON-HORMONAL COMPOSITIONS AND METHODS FOR MALE CONTRACEPTION
[patent_app_type] => utility
[patent_app_number] => 16/362081
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362081
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/362081 | Non-hormonal compositions and methods for male contraception | Mar 21, 2019 | Issued |
Array
(
[id] => 16815690
[patent_doc_number] => 11000488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Treating pain using desmetramadol
[patent_app_type] => utility
[patent_app_number] => 16/362139
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 23
[patent_no_of_words] => 22867
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/362139 | Treating pain using desmetramadol | Mar 21, 2019 | Issued |